… is concordant with the known postmortem findings of COVID-19 (3) although we demonstrate
… of organizing pneumonia of other causes, and it was with this rationale that post–COVID-19 …

… and clinical similarities of COVID-19 and the fibrotic process. … the long-term pulmonary
consequences of COVID-19 remain … interstitial pneumonia/fibrotic ILD in survivors of COVID-19 …

… without pre-existing lung disease. The challenge … COVID-19 and the interstitium, as well
as the model of care for patients with pre-existing ILD and those patients with persistent disease …

… previously reported risk factors for severe COVID-19 (1–6), it has been hypothesized that
patients with interstitial lung diseases (ILDs) may have poorer outcomes from COVID-19 (7). In …

… patients with existing interstitial lung disease were at very … with COVID-19, especially if they
have reduced prior lung … heart disease, and other non-ILD chronic pulmonary diseases), and …

… mortality from coronavirus disease 2019 (COVID-19). … residual pulmonary sequelae in
survivors, given that the lungs are … The initial waves of acute, severe COVID-19 were profoundly …

… their knowledge of this novel and complex condition in real time. This … COVID-19 with
respect to residual pulmonary disease and accurate reporting of the incidence of post–COVID-19 …

… lung disease, the duration of pulmonary abnormalities will be related to the severity of their
acute COVID-19 … In summary, the varying extent of pulmonary fibrosis and lung function …

… and poor prognoses of COVID-19. Asthma is … COVID-19 [12, 13]. However, there are
very limited data on the natural course of COVID-19 in patients with interstitial lung disease …

… We report a case of interstitial lung disease (ILD) after COVID-19 vaccination and review the
literature on influenza vaccine-related ILDs. This review is favourable as influenza vaccines …